Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Repoceuticals A/S
A/S
Active
CVR 36494433
Slotsmarken 12, 2970
Hørsholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2015 · 11 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Repoceuticals A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TB
Torsten Bjørn
Management
Management
2016
Former (2)
HL
Henrik Lasse Lindblad
Management
Management
2015 – 2016
CP
Charlotte Pahl
Deputy
Deputy
2019 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
HB
Henrik Bulskov
Chairman
Chairman
2025
CV
Christian Vinding Thomsen
Board of Directors
Board of Directors
2021
CP
Charlotte Pahl
Board of Directors
Board of Directors
2021
Former (4)
PM
Preben Møllegaard Grundtvig
Board of Directors
Board of Directors
2019 – 2025
NS
Nete Søgaard Poulsen
Board of Directors
Board of Directors
2019 – 2023
TP
Troels Peter Troelsen
Shareholders
As of last annual report
DMZ HOLDING ApS — 15–19.99%
Beier Holding ApS — 10–14.99%
Anpartsselskabet af 11.11.2019 — 10–14.99%
NIELS ERIK JESPERSEN HOLDING ApS — 10–14.99%
PM Group Holding ApS — 5–9.99%
CLINICURO ApS — 5–9.99%
TT 1919 ApS — 5–9.99%
JARO HOLDING ApS — 25–33.32%
Støckler Invest ApS — 10–14.99%
ASBA CONSULTING ApS — 15–19.99%
VULKAN INVEST ApS — 5–9.99%
SAX FINANS ApS — 10–14.99%
Scandinavian Shares Holding AB — 20–24.99%
BREGNERØDVEJ AUTO ApS — 5–9.99%
MLL-001 ApS — 10–14.99%
Morten Peter Friis — 25–33.32%
KJELDSBJERGGAARD ApS — 5–9.99%
LMJ Trading & Import ApS — 5–9.99%
FINANSMANAGEMENT ApS — 5–9.99%
100%
Shareholder
Type
Ownership
Votes
Since
DMZ HOLDING ApS
Company
15–19.99%
15–19.99%
2025
Beier Holding ApS
Company
10–14.99%
10–14.99%
2021
Anpartsselskabet af 11.11.2019
Company
10–14.99%
10–14.99%
2021
NIELS ERIK JESPERSEN HOLDING ApS
Company
10–14.99%
10–14.99%
2019
PM Group Holding ApS
Company
5–9.99%
5–9.99%
2020
CLINICURO ApS
Company
5–9.99%
5–9.99%
2016
TT 1919 ApS
Company
5–9.99%
5–9.99%
2019
JARO HOLDING ApS
Company
25–33.32%
25–33.32%
2015
Støckler Invest ApS
Company
10–14.99%
10–14.99%
2016
ASBA CONSULTING ApS
Company
15–19.99%
15–19.99%
2015
VULKAN INVEST ApS
Company
5–9.99%
5–9.99%
2015
SAX FINANS ApS
Company
10–14.99%
10–14.99%
2018
Scandinavian Shares Holding AB
Company
20–24.99%
20–24.99%
2017
BREGNERØDVEJ AUTO ApS
Company
5–9.99%
5–9.99%
2016
MLL-001 ApS
Company
10–14.99%
10–14.99%
2021
Morten Peter Friis
Individual
25–33.32%
25–33.32%
2017
KJELDSBJERGGAARD ApS
Company
5–9.99%
5–9.99%
2018
LMJ Trading & Import ApS
Company
5–9.99%
5–9.99%
2017
FINANSMANAGEMENT ApS
Company
5–9.99%
5–9.99%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Repoceuticals A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Chairman
Chairman
2024 – 2025
SG
Sigbjørn Georg Nielsen Kjærgård
Chairman
Chairman
2019 – 2024
